For example, increased adiponectin in older DS patients could decrease cancer risk already low due to anti-angiogenesis genes on chromosome 21, and at the same time increase Alzheimer’s disease risk. This evidence concerns the gene ADIPOQ and early-onset autosomal dominant Alzheimer disease.